Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement |
| |
Authors: | Sun Xicheng Qiu Jian Strong Sarah A Green Louis S Wasley Jan W F Colagiovanni Dorothy B Mutka Sarah C Blonder Joan P Stout Adam M Richards Jane P Chun Lawrence Rosenthal Gary J |
| |
Affiliation: | a N30 Pharmaceuticals LLC, 3122 Sterling Circle, Suite 200, Boulder, CO 80301, USA b Simpharma LLC, 1 Stone Fence Lane, Guilford, CT 06437, USA c Emerald BioStructures, 7869 NE Day Road West, Bainbridge Island, WA 98110, USA |
| |
Abstract: | S-Nitrosoglutathione reductase (GSNOR) is a member of the alcohol dehydrogenase family (ADH) that regulates the levels of S-nitrosothiols (SNOs) through catabolism of S-nitrosoglutathione (GSNO). GSNO and SNOs are implicated in the pathogenesis of many diseases including those in respiratory, cardiovascular, and gastrointestinal systems. The pyrrole based N6022 was recently identified as a potent, selective, reversible, and efficacious GSNOR inhibitor which is currently undergoing clinical development. We describe here the synthesis and structure-activity relationships (SAR) of novel pyrrole based analogues of N6022 focusing on scaffold modification and propionic acid replacement. We identified equally potent and novel GSNOR inhibitors having pyrrole regioisomers as scaffolds using a structure based approach. |
| |
Keywords: | GSNOR, S-nitrosoglutathione reductase GSNO, S-nitrosoglutathione NO, nitric oxide SNOs, nitrosothiols |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|